Clinical Trial Update: Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating pyrimethamine for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma; results posted in 2022…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Pyrimethamine (Pyrimethamine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-12-01